Position in BIO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$211,399
-$12,510 QoQ
Shares Held
720
-2.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#265
of 398 holders
Holding Since
Dec 2020
10 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $216,953,902 across 97 Medical Devices names. BIO ranks #40 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
607,526 | $55,126,909 | |
| 2 | SYK |
Stryker Corp
|
141,768 | $44,634,237 | |
| 3 | MDT |
Medtronic plc
|
503,456 | $39,385,362 | |
| 4 | EW |
Edwards Lifesciences Corp
|
278,920 | $25,231,103 | |
| 5 | BSX |
Boston Scientific Corp
|
206,271 | $8,803,646 | |
| 6 | DXCM |
Dexcom Inc
|
68,743 | $4,629,841 | |
| 7 | PODD |
Insulet Corp
|
27,762 | $4,226,764 | |
| 8 | STE |
STERIS plc
|
19,306 | $4,065,264 |
All Filings in BIO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $211,399 | 720 | Shares | Sole | 2026-08-11 | |
| 2025-12-31 | $223,909 | 739 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $210,853 | 752 | Shares | Sole | 2025-11-14 | |
| 2023-12-31 | $263,478 | 816 | Shares | Sole | 2024-02-15 | |
| 2022-06-30 | $216,315 | 437 | Shares | Sole | 2022-08-10 | |
| 2021-12-31 | $310,539 | 411 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $349,850 | 469 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $403,969 | 627 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $336,419 | 589 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $352,095 | 604 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||